BeatSarcoma feels very honored to count Dr. George Demetri, MD of Dana-Farber and Dr Robert Maki, MD, PhD of Memorial-Sloan Kettering on its Medical Advisory Board. Together with Dr Amreen Husain, MD of Stanford University, they will advise the BeatSarcoma Board on the best way to disburse research funds.
Dr George Demetri is Director of the Center for Sarcoma and Bone Oncology; Senior Vice President for Experimental Therapeutics; Director of the Ludwig Center at Dana-Farber/Harvard Cancer Center; executive director for Clinical and Translational Research at the Ludwig Institute for Cancer Research. and Associate Professor of Medicine, Harvard Medical School on its Medical Advisory Board.
Dr Robert Maki is a medical oncologist and co-leader of the adult Sarcoma Disease Management Team at Memorial Sloan-Kettering Cancer Center with a special interest in new therapies for the treatment of soft tissue and bone sarcomas, particularly metastatic disease. He is also trying to develop vaccines and other forms of immunological therapy against sarcomas to "teach" the immune system to attack tumor cells but not normal cells.
Please join us in welcoming both of them to our community!